InfuSystem Holdings Files 8-K for Regulation FD Disclosure

Ticker: INFU · Form: 8-K · Filed: Sep 12, 2024 · CIK: 1337013

Infusystem Holdings, INC 8-K Filing Summary
FieldDetail
CompanyInfusystem Holdings, INC (INFU)
Form Type8-K
Filed DateSep 12, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: regulation-fd, disclosure

TL;DR

InfuSystem Holdings filed an 8-K today for a Reg FD disclosure. Details TBD.

AI Summary

InfuSystem Holdings, Inc. filed an 8-K on September 12, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, only that it is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

This filing indicates InfuSystem Holdings is making a public disclosure required by Regulation FD, which ensures all investors receive important information simultaneously.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The filing does not specify the content of the Regulation FD disclosure, only that one is being made.

What is the purpose of a Regulation FD Disclosure?

Regulation FD requires that when a company discloses material nonpublic information to certain persons, it must make public disclosure of that information.

When was this 8-K filing submitted?

The 8-K filing was submitted on September 12, 2024.

What is the principal executive office address for InfuSystem Holdings, Inc.?

The principal executive offices are located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.

What is InfuSystem Holdings, Inc.'s Commission File Number?

InfuSystem Holdings, Inc.'s Commission File Number is 001-35020.

Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-09-12 17:05:53

Filing Documents

01 - Regulation FD Disclosure

Item 7.01 - Regulation FD Disclosure InfuSystem Holdings, Inc. (the "Company") hereby furnishes the information set forth in the Investor Presentation dated September 12, 2024, which is attached hereto as Exhibit 99.1. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the Investor Presentation attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

01 - Financial Statements and Exhibits

Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 InfuSystem Holdings, Inc. Investor Presentation dated September 12, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: September 12, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing